Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, Adam L.·2015·Behavioural Brain Research
DOI 10.1016/j.bbr.2014.07.016

Cited by (316)

Items 201–300 of 316

  1. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence
    Marta Bassi, Sabrine Bilel, Micaela Tirri, Giorgia Corli, Fabiana Di Rosa, Adolfo Gregori, Alaaldin M. Alkilany, Ousama Rachid, E. Roda, Giorgio Zauli et al. · 2024 · Psychopharmacology
  2. Asymmetric syntheses of (R)-4-halo-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines, important 5-HT2C agonist precursors
    Thomas O. Schrader, Xiuwen Zhu, Michelle Kasem, Sufang Li, Chunyan Liu, Albert Ren, Chunrui Wu, Graeme Semple · 2018 · Tetrahedron Letters
  3. Singularity and consciousness: A neuropsychological contribution
    Edward H.F. de Haan, H. Steven Scholte, Yaïr Pinto, Nicoletta Foschi, Gabriele Polonara, Mara Fabri · 2021 · Journal of Neuropsychology
  4. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
    Teresa Reynolds de Sousa, João Rema, Sergio Eduardo de Carvalho Machado, Filipa Novais · 2021 · Current Topics in Medicinal Chemistry
  5. Stretching and squeezing of neuronal log firing rate distribution by psychedelic and intrinsic brain state transitions
    Bradley Dearnley, Martynas Dervinis, Melissa Shaw, Michael Okun · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  6. 5-HT2A receptors shape whole-brain monoaminergic coherence in male mice
    Jasmine Jade Butler, Margherita Virgili, Giuseppe Di Giovanni, Abdeslam Chagraoui, Anna Beyeler, Philippe De Deurwaerdère · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  7. An exploration of the relationships between the effects of psilocybin on behavior, 5-HT 2A receptor occupancy, and neuroplastic effects in mice
    Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoë A. Hughes · 2026 · Journal of Psychopharmacology
  8. Membrane Permeation of Psychedelic Tryptamines by Dynamic Simulations
    Vito F. Palmisano, Claudio Agnorelli, Andrea M. Fagiolini, David Erritzøe, David Nutt, Shirin Faraji, Juan José Nogueira · 2024 · Biochemistry
  9. Is music a drug? How music listening may trigger neurochemical responses in the brain
    Mark Reybrouck, Edith Van Dyck · 2024 · Musicae Scientiae
  10. Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey
    Bruno Roméo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Pascale Piolino, Amine Benyamina · 2024 · Journal of Psychoactive Drugs
  11. The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication
    Elena Koning, Marco Solmi, Elisa Macedo Brietzke · 2024 · Trends in Psychiatry and Psychotherapy
  12. Hallucinogenic Drugs: A New Study Answers Old Questions about LSD
    Adam L. Halberstadt · 2017 · Current Biology
  13. Sex-Dependent Skin Aging and Rejuvenation Strategies
    Marta Gerasymchuk, Gregory Ian Robinson, Nataliia Vardinska, Samuel Abiola Ayedun, Sandra Chinwe Alozie, J. Wesley Robinson, Olga Kovalchuk, Igor Kovalchuk · 2023 · Dermato
  14. Discovery of a lead series of potent benzodiazepine 5-HT2C receptor agonists with high selectivity in functional and binding assays
    Albert Ren, Xiuwen Zhu, Konrad Feichtinger, Juerg Lehman, Michelle Kasem, Thomas O. Schrader, Amy SM Wong, Huong Dang, Minh Le, John M. Frazer et al. · 2019 · Bioorganic & Medicinal Chemistry Letters
  15. Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis
    Iasmina-Alexandra Predescu, Alex-Robert Jîjie, Dalia Pătrașcu, Aida-Luisa-Vanessa Pasc, Elisaveta Ligia Piroș, Cristina Maria Trandafirescu, Cristian Iulian Oancea, Cristina Adriana Dehelean, Elena-Alina Moacă · 2025 · Pharmacy
  16. Rapid, Open-Source, and Automated Quantification of the Head Twitch Response in C57BL/6J Mice Using DeepLabCut and Simple Behavioral Analysis
    Alexander D. Maitland, Nicholas R. Gonzalez, Donna M. Walther, Francisco Lucas F. Pereira, Michael H. Baumann, Grant C. Glatfelter · 2025 · ACS Pharmacology & Translational Science
  17. Integrated Computer-Aided Drug Design: Advances in GPCR Natural Ligand Discovery
    Abdullahi İbrahim Uba · 2025 · Cell Biochemistry and Biophysics
  18. Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential.
    Deborah Rudin, Jan Valenta, H. Rolli, M. Liechti, Dino Luethi · 2026 · European Neuropsychopharmacology
  19. Restoring oscillatory dynamics in Alzheimer’s disease: A laminar whole-brain model of serotonergic psychedelic effects
    Jan C. Gendra, Edmundo Lopez-Sola, Francesca Castaldo, Èlia Lleal-Custey, Roser Sanchez-Todo, Jakub Vohryzek, Ricardo Salvador, Ralph G. Andrzejak, Giulio Ruffini, the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Network Neuroscience
  20. Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats—pharmacokinetics, effects on behaviour and thermoregulation
    Kateřina Syrová, Klára Šíchová, Hynek Danda, Eva Lhotková, Pascal Jorratt, Nikola Pinterová, Čestmír Vejmola, Lucie Olejníková, Kateřina Hájková, Martin Kuchař et al. · 2023 · Frontiers in Pharmacology
  21. Analysis of a New Potent Hallucinogen, 25-B-NBOMe, in Blotters by High-Performance Thin-Layer Chromatography
    Boris Ettienne Duffau, Cristian Camargo, Bruce K. Cassels, Marcelo Javier Kogan, Edwar Fuentes · 2015 · Journal of Planar Chromatography – Modern TLC
  22. Dream over life: Psychedelic terphenyl derivative induce hallucination via cannabinoid receptor 1
    F A Fauzi, Meng Shien Goh, Syed Ahmad Tajudin Tuan Johari, Fatimah Hashim, Muhamad Fairus Noor Hassim · 2018 · IOP Conference Series Materials Science and Engineering
  23. Hallucinogens—psychedelics and dissociative drugs
    Mark Petersen, Uttam C Garg, Hemamalini Ketha · 2020 · Elsevier eBooks
  24. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats
    Karolina Noworyta, Anna Maria Górska, Krystyna Gołembiowska · 2018 · Pharmacological Reports
  25. 5-HT2CR Is as Important as 5-HT2AR in Inducing Hallucinogenic Effects in Serotonergic Compounds
    Raly James Perez Custodio, Darlene Mae Ortiz, Hyun Jun Lee, Leandro Val Sayson, Danilo B. Buctot, Mikyung Kim, Yong Sup Lee, Kyeong‐Man Kim, Jae Hoon Cheong, Hee Jin Kim · 2022 · SSRN Electronic Journal
  26. DMT-induced shifts in criticality correlate with ego-dissolution
    Mona Irrmischer, Marco Aqil, Lisa Xiaolu Luan, Tongyu Wang, Hessel Engelbregt, Robin Lester Carhart-Harris, Klaus Linkenkaer‐Hansen, Christopher Timmermann · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Role of neural oscillations in depression: highlights on gamma oscillations
    Yong‐Yu Yin, Yunfeng Li · 2026 · Translational Psychiatry
  28. Toward a positive psychology of psychoactive drug use
    Kevin O. St. Arnaud · 2021 · Drugs Education Prevention and Policy
  29. Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action
    Eric A. Miller, Christy Capone, Erica M. Eaton, Robert M. Swift, Carolina L. Haass‐Koffler · 2025 · CNS Drugs
  30. Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis
    M. D. Rafter, Kevin C.F. Fone, Paula M. Moran · 2015 · Handbook of behavioral neuroscience
  31. Ética en el uso de psicodélicos: la definición de las drogas ilícitas bajo la óptica de la bioética crítica
    Sergio Alexandre Liblik, Thiago Rocha da Cunha, Carmem Silvia da Fonseca Kummer Liblik, Diego Nicolás Biscioni, Dennys Robson Girardi · 2024 · Salud Colectiva
  32. The enculturation problem
    Thomas K. Metzinger · 2024 · Oxford University Press eBooks
  33. Serotonin and serotonin receptors in hallucinogen action
    Adam L. Halberstadt, David E. Nichols · 2020 · Handbook of behavioral neuroscience
  34. Self-Enhancement and the Medial Prefrontal Cortex: The Convergence of Clinical and Experimental Findings
    Saeed Yasin, Anjel Fierst, Harper Keenan, Amelia Knapp, Katrina Gallione, Tessa Westlund, Sydney Kirschner, Sahana Vaidya, Christina Qiu, Audrey Rougebec et al. · 2022 · Brain Sciences
  35. Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice
    Christopher W. Thomas, Cristina Blanco‐Duque, Benjamin J. B. Bréant, Guy M. Goodwin, Trevor Sharp, David M. Bannerman, Vladyslav V. Vyazovskiy · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context
    Grace Stockwell, Nicholas R. Hoeh, Francesca A. Fogarty, Cerys Clayden, Lisa Reynolds · 2025 · Journal of Psychoactive Drugs
  37. The synaptic triad in depression: how stress-related pathways converge on BDNF, NMDA receptor, and MMP-9
    Bartosz Adam Frycz, Magdalena Dutsch-Wicherek, Olga Płaza, Agata Szulc, Monika Bijata, Jakub Włodarczyk, Joanna Dzwonek · 2026 · Pharmacological Reports
  38. Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials
    Renan Massanobu Maekawa, Lorena Terene Lopes Guerra, José Carlos Bouso, Jaime E. C. Hallak, RAFAEL GUIMARÃES DOS SANTOS · 2025 · Psychoactives
  39. Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics
    Guy A. Higgins, Cam MacMillan, Inés de Lannoy, Carolyn Tyler, Malik Slassi · 2025 · Journal of Psychopharmacology
  40. Psilocybin alters visual contextual computations
    Marco Aqil, Gilles de Hollander, Nina Vreugdenhil, Tomas H. J. Knapen, Serge Olaf Dumoulin · 2025 · Nature Communications
  41. An Argument for Amphetamine-Induced Hallucinations in an Invertebrate
    Anne H Lee, Cindy L. Brandon, Jean C. Y. Wang, William N. Frost · 2018 · Frontiers in Physiology
  42. Investigation of the Roles of the Adenosine A(2A) and Metabotropic Glutamate Receptor Type 5 (mGlu5) Receptors in Prepulse Inhibition and CREB Signaling in a Heritable Rodent Model of Psychosis
    Anthony M. Cuozzo, Loren D. Peeters, Cristal D. Ahmed, Liza J. Wills, Justin T. Gass, Russell W. Brown · 2025 · Cells
  43. Synthetic cannabinoid: prevalence, mechanisms of addiction development, mental disorders associated with the use of synthetic cannabinoid
    Andrey Viktorovich Antsyborov, Vladimir Valerievich Mrykhin · 2017 · Interactive science
  44. Yagé: Crisis de occidente y trabajo espiritual
    Javier Ávila, Mariana Pedroza, Oscar Angulo · 2019 · Universidad y Salud
  45. Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
    Ron Shore, K. Dobson, Nina Thomson, Nigel Barnim, Hailey P Bergman, Katie Rideout, Sandra McKeown, Mary C. Olmstead, Craig E. Goldie, Éric C. Dumont · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Serotonergic psychedelics for depression: A comprehensive overview
    Wingert, A.M., Agnorelli, C., Peill, J., Reed, S., Nutt, D.J., Erritzoe, D. · 2025 · International Review of Neurobiology
  47. Mimosa tenuiflora (Willd.) Poir e Anadenanthera colubrina como alternativas no tratamento da adicção às drogas
    Patrícia Caroline Machado de Sousa, Italo Nunes Arrais de Sousa, Lucas Luan Lima Leite, André Luiz Ozório Oliveira, Karina Aparecida da Silva Souza, Jôslanne dos Santos Soares, Melquisedeque da Rocha Viana, Maurício Pires de Moura do Amaral · 2021 · Research Society and Development
  48. Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice
    Paul J. Fletcher, Zhaoxia Li, Xiao Dong Ji, Anh Dzung Lê · 2023 · Pharmacology Biochemistry and Behavior
  49. Effects and Toxicity of Hallucinogenic New Psychoactive Substances From the Perspectives of e-Psychonauts
    Abdullah Al Hamid, Rebecca McGuinness, Dhiya Al‐Jumeily, Sulaf A. Assi · 2024 · Journal of Drug Issues
  50. In vitro metabolic fate of 1-[3-(trimethylsilyl)propanoyl] lysergic acid diethylamide (1S-LSD), a silicon-containing LSD analog
    Yuki Azuma, Misa Tanaka, Akiko Asada, Takahiro Doi · 2025 · Forensic Toxicology
  51. Psychiatric aspects of designer drugs and new psychoactive substances consumption
    Vladimir Valerievich Mrykhin, Andrey Viktorovich Antsyborov · 2017 · Interactive science
  52. Psilocybin based therapy for cancer related distress, a systematic review and meta analysis
    Camile Bahi · 2019 · arXiv (Cornell University)
  53. Halluzinogene
    Tomislav Majić, Euphrosyne Gouzoulis‐Mayfrank, Michael Schaub · 2018 · Elsevier eBooks
  54. Psychedelics: Recent Philosophical Discussions
    Chris Letheby · 2024 · Springer eBooks
  55. Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences
    Bruno Roméo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Pascale Piolino, Amine Benyamina · 2025 · Journal of Psychoactive Drugs
  56. Facing trauma under the influence of psychedelics: A phenomenological study with Nova rave survivors
    Guy Simon, Maya Gal-Birman, Nir Tadmor, Demian Halperin · 2025 · Journal of Psychopharmacology
  57. Pharmacodynamic effects and plasma pharmacokinetics of N, N-dimethyltryptamine after intranasal versus subcutaneous administration in male rats
    Michael H. Baumann, Grant C. Glatfelter, Sara E. Walton, Alex J. Krotulski, Christopher G. Witowski, Jacqueline L. von Salm · 2025 · Psychopharmacology
  58. Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students: A Cross-Sectional Study
    Warnakulasuriya S. A. V. Fernando, Aviad David, Nicolo Cianci, Anastasija Ševčenko, Jeļena Vrubļevska, Elmārs Rancāns, Lubova Renemane · 2025 · International Journal of Environmental Research and Public Health
  59. Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review
    Jennifer Pincombe, Martin L Williams, Sean P. Carruthers, Susan Lee Rossell · 2025 · Psychedelic Medicine
  60. Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey
    Sahba Afsharnia, Vivian Liang, Yona Lunsky, A Orsini, Ami Tint, Hsiang‐Yuan Lin · 2025 · PLOS mental health.
  61. Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine
    Alan C. Courtes, Blake Myers, Noah Daly, Greg Jones, Jair C. Soares, Carlos A. Zarate, Rodrigo Machado‐Vieira · 2026 · General Hospital Psychiatry
  62. Sleep-pain co-regulation by targeting the 5-HT2A receptor subtype: Mechanisms, promises and perils
    S. Mohammad Ahmadi‐Soleimani, Hossein Azizi, Omid Azizi, Farimah Beheshti · 2026 · Behavioural Brain Research
  63. Comparative study of different column types for the separation of polar basic hallucinogenic alkaloids
    Somandla Ncube, Anna Poliwoda, Ewa Cukrowska, Piotr Paweł Wieczorek, Luke Chimuka · 2016 · South African Journal of Chemistry
  64. Substances of Abuse and the Brain
    Alisha R. Moreland-Capuia · 2019 · Springer eBooks
  65. Possível uso da Psilocibina no tratamento psiquiátrico, incluindo sequelas da COVID-19
    Myla Christie Araújo Custódio Bonifácio, Pietra Bruna Barbosa Bento, Kaynara Trevisan, Renata Cristina-Pereira, Micheli Patrícia de Fátima Magri, Tales Alexandre Aversi‐Ferreira · 2021 · Research Society and Development
  66. Psychedelika
    Maximilian von Heyden, Henrik Jungaberle · 2017 · Springer eBooks
  67. Actions of Drugs on The Brain and CNS Disorders
    Thomas P. Blackburn · 2017 · Royal Society of Chemistry eBooks
  68. CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.
    Astrid Kaiserman, Laetitia Vanderijst, Charles Kornreich · 2024 · Psychiatria Danubina
  69. Psychedelics: The Journal of Psychedelic and Psychoactive Drug Research – Charting a new course in psychedelic science
    Júlio Licinio · 2024 · Psychedelics.
  70. Intercultural, intermolecular: An ethnobotanical examination of the potential therapeutic value of LSD for the treatment of depression
    Karsten Fatur · 2019 · Journal of Psychedelic Studies
  71. New psychoactive substances: psychiatrist's view
    Andrey Viktorovich Antsyborov, Irina Vladimirovna Dubatova · 2019 · Interactive science
  72. Screening/Spot/Colour test of hallucinogens
    A K Jaiswal, Kamna Sharma, Sally Lukose, M Gupta · 2020 · IP International Journal of Forensic Medicine and Toxicological Sciences
  73. Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT2C receptor
    Thomas O. Schrader, Xiuwen Zhu, Michelle Kasem, Albert Ren, Chunyan Liu, Chunrui Wu, Huong Dang, Minh Le, Joel Gatlin, Kelli Chase et al. · 2021 · Bioorganic & Medicinal Chemistry Letters
  74. Psychedelic-assisted psychotherapy for existential suffering: Facilitating self-transcendence at the end of life.
    Kevin O. St. Arnaud · 2022
  75. 2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects
    Chu Hsien Lim, Brian D. Kangas, Jack Bergman · 2018
  76. Serotonergic modulation of visual neurons in Drosophila melanogaster
    Maureen M Sampson, Katherine M Myers Gschweng, Ben J Hardcastle, Shivan L Bonanno, Tyler R. Sizemore, Rebecca C Arnold, Fuying Gao, Andrew M Dacks, Mark Arthur Frye, David E Krantz · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol
    Jennifer Pincombe, Martin L Williams, Sean P. Carruthers, Susan Lee Rossell · 2024
  78. Avaliação toxicológica da ayahuasca em ratos Wistar : comportamento e toxicidade reprodutiva em machos
    Alana de Fátima Andrade Santos · 2016
  79. Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats
    Keli A. Herr · 2017 · ScholarWorks - WMU (Western Michigan University)
  80. Micetismos: Parte 4: Síndromes tempranos con síntomas complejos
    Alicia Beatriz Pomilio, Stella Maris Battista, Ángel Alonso · 2019 · Redalyc (Universidad Autónoma del Estado de México)
  81. Subjektívne vnímané riziká užívania psychedelík
    Ústav aplikovanej psychológie, FSEV UK, Bratislava, Slovakia, Marek Lukačovič, Radomír Masaryk, Ústav aplikovanej psychológie, FSEV UK, Bratislava, Slovakia · 2021 · Ceskoslovenska psychologie
  82. The use of psychoactive substances in the treatment of mental disorders
    K. Karaś, Katarzyna Groblińska, K. Szczygieł, J. Samochowiec · 2021 · Alcoholism and Drug Addiction
  83. Psychedelika
    Maximilian von Heyden, Henrik Jungaberle · 2017 · Springer eBooks
  84. Psilocybin's Emerging Role in Combating Depressive Disorder
    Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek · 2023 · Journal of Education Health and Sport
  85. Membrane Permeation of Psychedelic Compounds
    Vito F. Palmisano, Claudio Agnorelli, Andrea M. Fagiolini, David Erritzøe, David Nutt, Shirin Faraji, Juan José Nogueira · 2023 · ChemRxiv
  86. Evidencias y perspectivas del potencial antidepresivo del “alcaloide mágico” psilocibina: una revisión narrativa
    María Marcela Velásquez Toledo · 2023 · Cultura y Droga
  87. If psychedelics heal, how do they do it?
    Carolyn M. Beans · 2024 · Proceedings of the National Academy of Sciences
  88. The mechanism of hallucinations caused by lysergic acid diethylamide
    Chaoyi Fan, Jiayi Li, Shaohuan Yu · 2024 · MedScien
  89. Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence
    Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij M. Satodiya, Rashmi Shukla, Samer El Hayek · 2024 · Current Psychopharmacologye
  90. Psychedelics: a window into perceptual processing
    Berit “Brit” Brogaard, Dimitria Electra Gatzia · 2024 · Oxford University Press eBooks
  91. Halluzinogene
    Tomislav Majić, Euphrosyne Gouzoulis‐Mayfrank, Michael Schaub · 2024 · Elsevier eBooks
  92. Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review
    Ron Shore, K. Dobson, Nina Thomson, Nigel Barnim, Hailey P Bergman, Katie Rideout, Sandra McKeown, Mary C. Olmstead, Craig E. Goldie, Éric C. Dumont · 2025 · Journal of Psychedelic Studies
  93. Hallucinogen Use Disorder
    Nathen A. Spitz · 2025 · Springer eBooks
  94. Psychedelics: Recent Philosophical Discussions
    Chris Letheby · 2025 · Springer eBooks
  95. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review
    Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari · 2025 · Brazilian Journal of Science
  96. Additional file 1 of MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
    Robin J. Murphy, Rachael L. Sumner, William James Evans, Menkes, David, Ingo Lambrecht, Rhys Ponton, Frederick Sundram, Nicholas R. Hoeh, Sanya Ram, Lisa Reynolds et al. · 2021 · Figshare
  97. Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD
    Sarah Shnayder, Gabrielle Agin-Liebes, Troy Hubert, Terence H. W. Ching, Jamila Hokanson, Christopher Pittenger, Benjamin Kelmendi, Thomas G. Adams · 2026 · Frontiers in Psychiatry
  98. In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard
    Yuki Azuma, Akiko Asada, Misa Tanaka, Takahiro Doi · 2026 · Drug Testing and Analysis
  99. Neurotransmitters and Neural Pathways
    Julia Steigerwald Schnall · 2026 · Springer eBooks
  100. Examining Normative Male Alexithymia in Men Reporting Psychedelic and Non-Psychedelic Self-Transcendent Experiences
    Shaun Sleightholm, Catherine O’Neill · 2026 · Psychological Reports